title: FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety.
authors.affiliation: US Food and Drug Administration, Rockville, MD 20852, USA. chintamani.atreya@fda.hhs.gov
authors.forename: Chintamani
authors.initials: C
authors.lastname: Atreya
authors.forename: Hira
authors.initials: H
authors.lastname: Nakhasi
authors.forename: Paul
authors.initials: P
authors.lastname: Mied
authors.forename: Jay
authors.initials: J
authors.lastname: Epstein
authors.forename: James
authors.initials: J
authors.lastname: Hughes
authors.forename: Marta
authors.initials: M
authors.lastname: Gwinn
authors.forename: Steven
authors.initials: S
authors.lastname: Kleinman
authors.forename: Roger
authors.initials: R
authors.lastname: Dodd
authors.forename: Susan
authors.initials: S
authors.lastname: Stramer
authors.forename: Mark
authors.initials: M
authors.lastname: Walderhaug
authors.forename: Peter
authors.initials: P
authors.lastname: Ganz
authors.forename: Raymond
authors.initials: R
authors.lastname: Goodrich
authors.forename: Clark
authors.initials: C
authors.lastname: Tibbetts
authors.forename: David
authors.initials: D
authors.lastname: Asher
mesh_terms: D058731:Blood Safety / Q000379:methods / Q000639:trends; D001803:Blood Transfusion / Q000592:standards*; D021821:Communicable Diseases, Emerging / Q000097:blood / Q000175:diagnosis / Q000635:transmission*; D004493:Education; D006292:Health Priorities; D006801:Humans; D018570:Risk Assessment; D014481:United States; D014486:United States Food and Drug Administration